167 related articles for article (PubMed ID: 36274283)
1. Brain volumetric correlates of remotely versus in-person administered symbol digit modalities test in multiple sclerosis.
Buyukturkoglu K; Dworkin JD; Leiva V; Provenzano FA; Guevara P; De Jager PL; Leavitt VM; Riley CS
Mult Scler Relat Disord; 2022 Dec; 68():104247. PubMed ID: 36274283
[TBL] [Abstract][Full Text] [Related]
2. In-person and remote administrations of the symbol digit modalities test are interchangeable among persons with multiple sclerosis.
Levy S; Dvorak EM; Graney R; Staker E; Sumowski JF
Mult Scler Relat Disord; 2023 Mar; 71():104553. PubMed ID: 36764285
[TBL] [Abstract][Full Text] [Related]
3. Traumatic hemorrhagic brain injury: impact of location and resorption on cognitive outcome.
Martin RM; Wright MJ; Lutkenhoff ES; Ellingson BM; Van Horn JD; Tubi M; Alger JR; McArthur DL; Vespa PM
J Neurosurg; 2017 Mar; 126(3):796-804. PubMed ID: 27231979
[TBL] [Abstract][Full Text] [Related]
4. Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume.
Bisecco A; Stamenova S; Caiazzo G; d'Ambrosio A; Sacco R; Docimo R; Esposito S; Cirillo M; Esposito F; Bonavita S; Tedeschi G; Gallo A
Brain Imaging Behav; 2018 Feb; 12(1):20-28. PubMed ID: 28083844
[TBL] [Abstract][Full Text] [Related]
5. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
6. Remote administration of the symbol digit modalities test to individuals with multiple sclerosis is reliable: A short report.
Eilam-Stock T; Shaw MT; Sherman K; Krupp LB; Charvet LE
Mult Scler J Exp Transl Clin; 2021; 7(1):2055217321994853. PubMed ID: 33643663
[TBL] [Abstract][Full Text] [Related]
7. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
[TBL] [Abstract][Full Text] [Related]
8. Exploring Neural Efficiency in Multiple Sclerosis Patients during the Symbol Digit Modalities Test: A Functional Magnetic Resonance Imaging Study.
Fittipaldi-Márquez MS; Cruz-Gómez ÁJ; Sanchis-Segura C; Belenguer A; Ávila C; Forn C
Neurodegener Dis; 2017; 17(4-5):199-207. PubMed ID: 28538226
[TBL] [Abstract][Full Text] [Related]
9. Single MRI-Based Volumetric Assessment in Clinical Practice Is Associated With MS-Related Disability.
D'hooghe MB; Gielen J; Van Remoortel A; D'haeseleer M; Peeters E; Cambron M; De Keyser J; Nagels G
J Magn Reson Imaging; 2019 May; 49(5):1312-1321. PubMed ID: 30597656
[TBL] [Abstract][Full Text] [Related]
10. Association between symbol digit modalities test and regional cortex thickness in young adults with relapsing-remitting multiple sclerosis.
Tao Y; XueSong Z; Xiao Y; YueZhi K; Xin W; YanPing T; Lei W; YongPing F
Clin Neurol Neurosurg; 2021 Aug; 207():106805. PubMed ID: 34280674
[TBL] [Abstract][Full Text] [Related]
11. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal subfields and thalamic nuclei associations with clinical outcomes in multiple sclerosis: An ultrahigh field MRI study.
Santini T; Chen C; Zhu W; Liou JJ; Walker E; Venkatesh S; Farhat N; Sajewski A; Alkhateeb S; Saranathan M; Xia Z; Ibrahim TS
Mult Scler Relat Disord; 2024 Jun; 86():105520. PubMed ID: 38582026
[TBL] [Abstract][Full Text] [Related]
13. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T
Louapre C; Govindarajan ST; Giannì C; Madigan N; Nielsen AS; Sloane JA; Kinkel RP; Mainero C
Neuroimage Clin; 2016; 12():879-886. PubMed ID: 27872810
[TBL] [Abstract][Full Text] [Related]
14. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
15. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
Riccitelli GC; Pagani E; Rodegher M; Colombo B; Preziosa P; Falini A; Comi G; Filippi M; Rocca MA
Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009
[TBL] [Abstract][Full Text] [Related]
16. A validation study for remote testing of cognitive function in multiple sclerosis.
Barcellos LF; Horton M; Shao X; Bellesis KH; Chinn T; Waubant E; Bakshi N; Marcus J; Benedict RH; Schaefer C
Mult Scler; 2021 Apr; 27(5):795-798. PubMed ID: 32662747
[TBL] [Abstract][Full Text] [Related]
17. Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS.
DeLuca J; Schippling S; Montalban X; Kappos L; Cree BAC; Comi G; Arnold DL; Hartung HP; Sheffield JK; Liu H; Silva D; Cohen JA
Mult Scler Relat Disord; 2021 Feb; 48():102673. PubMed ID: 33454584
[TBL] [Abstract][Full Text] [Related]
18. Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients.
Conway DS; Planchon SM; Oh SH; Nakamura K; Thompson NR; Sakaie K; Ontaneda D
Mult Scler Relat Disord; 2021 Jan; 47():102635. PubMed ID: 33260053
[TBL] [Abstract][Full Text] [Related]
19. Symbol digit modalities test predicts decline of off-road driving ability in Japanese patients with multiple sclerosis.
Maeta M; Mizuno M; Okubo S; Ogasawara M; Terauchi T; Suzuki M; Akasaka H; Sato Y; Ohi K; Maeda T
Mult Scler Relat Disord; 2022 Dec; 68():104150. PubMed ID: 36055114
[TBL] [Abstract][Full Text] [Related]
20. A Rapid Electronic Cognitive Assessment Measure for Multiple Sclerosis: Validation of Cognitive Reaction, an Electronic Version of the Symbol Digit Modalities Test.
Middleton RM; Pearson OR; Ingram G; Craig EM; Rodgers WJ; Downing-Wood H; Hill J; Tuite-Dalton K; Roberts C; Watson L; Ford DV; Nicholas R;
J Med Internet Res; 2020 Sep; 22(9):e18234. PubMed ID: 32965240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
